Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Intradialytic HypotensionEnd Stage Renal Failure on Dialysis
Interventions
DEVICE

BVM-UF biofeedback

The Fresenius 5008 uses an ultrasound and temperature monitor incorporated into the machine to detect ultrasonic velocity and temperature changes to derive the total protein concentration, which is a sum of total plasma proteins and hemoglobin. The relative blood volume is calculated at by dividing the initial concentration of total protein by the total protein concentration at any given time, multiplied by 100. The HD software is based on the critical blood volume entered at the beginning of the dialysis session for each individual patient. The UF rate is adjusted based on the changes in the relative blood volume to the patient's critical relative blood volume.

DEVICE

Fresenius 5008 HD machine (Fresenius Medical Care, Bad Homburg, Germany)

For an 8-week period, patients in the best clinical practice (control) phase will use their same prescription as the run-in phase, dialysate sodium of 138mmol/L, dialysate calcium of 1.25mmol/L, dialysate temperature of 36oC, and constant UF rate. BVM will be disabled in this group.

Trial Locations (1)

T2N 2T9

Alberta Health Services Southern Alberta Renal Program, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT01988181 - Adjusting Fluid Removal Based on Blood Volume in Hemodialysis: A Randomized Study | Biotech Hunter | Biotech Hunter